TVGN: Tevogen Bio Holdings Inc

TVGN新闻

• 12:42 Tevogen Bio Explores Buyout To Boost Generics Platform - Tevogen Bio Holdings (NASDAQ:TVGN)
• 14:34 D. Boral Capital因稀释风险下调Tevogen Bio目标价至2美元
• 14:32 D. Boral Capital lowers Tevogen Bio stock price target to $2 on dilution risk
• 20:05 Tevogen董事会将评估潜在特别现金股息
• 20:05 Tevogen board to evaluate potential special cash dividend
• 04:49 Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)
• 21:38 贝莱德生物控股收到纳斯达克最低竞价不足通知
• 21:37 Tevogen Bio Holdings receives Nasdaq notice for minimum bid price deficiency
• 13:32 Tevogen announces $9-11 billion valuation for COVID-19 T cell therapy
• 19:57 Tevogen shares EBV treatment forecast with $3.5 billion revenue potential
• 20:21 Tevogen highlights need for SARS-CoV-2 treatments for immunocompromised
• 20:05 Tevogen reports 60% rise in institutional ownership in Q1 2025
• 19:41 Tevogen Bio stock rises amid $1 million grant funding
• 16:48 Tevogen executives and directors own over 74% of company stock